TEM
Tempus AI
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About TEM
Tempus Ai, Inc.
A company specializing in artificial intelligence precision medicine.
Professional Services
Invalid Date
06/14/2024
NASDAQ Stock Exchange
2400
12-31
Common stock
600 West Chicago Avenue, Suite 510, Chicago, Illinois 60654
--
Founded by Eric Lefkofsky, Tempus AI, Inc., was originally established in Delaware in August 2015 as Bioin LLC. The company strives to unleash the true power of precision medicine by creating intelligent diagnosis through the practical application of artificial intelligence (AI) in the field of healthcare. They make the tests smart by connecting the laboratory results with the patient's own clinical data, which in turn personalizes the results.
Company Financials
EPS
TEM has released its 2024 Q4 earnings. EPS was reported at -0.18, versus the expected -0.15, missing expectations. The chart below visualizes how TEM has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TEM has released its 2024 Q4 earnings report, with revenue of 200.68M, reflecting a YoY change of 35.85%, and net profit of -13.01M, showing a YoY change of 74.22%. The Sankey diagram below clearly presents TEM’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
